DOI: 10.12890/2025_005372
Juvenile dermatomyositis and hepatitis B viral infection
Authors
ahmabdahmad@uomosul.edu.iq
Keywords
Juvenile dermatomyositis, hepatitis B, Gottron’s papules, heliotrope rashAbstract
Juvenile dermatomyositis (JDM) is an uncommon autoimmune illness with unexplained origin. It affects the skin, skeletal muscles, and blood vessels.
This case report emphasizes an unusual case of an 8-year-old girl from Ninevah in Iraq, who presented with limb weakness and rash. She had a family history of hepatocellular carcinoma. The patient had hall mark features of JDM: heliotrope rash, Gottron’s papules, and progressive proximal muscle weakness as well as elevated muscle enzymes. A positive hepatitis B surface antigen with high viral load proved concomitant infection. Treatment started with entecavir and intravenous immunoglobulins, followed by methotrexate and corticosteroids leading to steady clinical improvement. Effective antiviral treatment in combination with immunosuppressants is crucial for treating autoimmune diseases without infection reactivation.
The correlation between hepatitis B infection and JDM is still obscure. This case suggests that that hepatitis B may lead to autoimmune diseases when there is a genetic susceptibility. This example adds to the scarce literature on JDM connection with viral hepatitis, highlighting the importance of being alert and using specialized treatment approaches in such cases.
References
- Wienke J, Deakin CT, Wedderburn LR, van Wijk F, van Royen-Kerkhof A. Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools. Front Immunol 2018;9:2951.
- Swafford C, Roach ES. Juvenile Dermatomyositis and the Inflammatory Myopathies. Semin Neurol 2020;40:342–348.
- Kobayashi I. Advances in Juvenile Dermatomyositis: Pathophysiology, Diagnosis, Treatment and Interstitial Lung Diseases—A Narrative Review. Children 2024;11:1046.
- Ramírez-Rivera J, Vega-Cruz AM, Jaume-Anselmi F. Polymyositis: rare complication of hepatitis B vaccination. An unusual cause of toxic shock syndrome. Bol Asoc Med P R 2003;95:13-16.
- Chou JW, Lin YL, Cheng KS, Wu PY, Reanne Ju T. Dermatomyositis Induced by Hepatitis B Virus-related Hepatocellular Carcinoma: A Case Report and Review of the Literature. Intern Med 2017;56:1831-1837.
- Pagnoux C, Guillevin L. Chapter 8 - Systemic and Autoimmune Manifestations of Hepatitis B Virus Infection. In: Ramos-Casals M, Khamashta M, Britó-Zeron P, Atzeni F, Teixidor JRBTH of SAD, editors. The Digestive Involvement in Systemic Autoimmune Diseases. Elsevier; 2017. 143-171. Available from: https://www.sciencedirect.com/science/article/pii/B9780444637079000088
- Rhim JW. Juvenile Dermatomyositis. J Rheum Dis 2022;29:14-21.
- Patil A, Lu J, Kassir M, Babaei M, Goldust M. Adult and juvenile dermatomyositis treatment. J Cosmet Dermatol 2023;22:395–401.
- Shenavandeh S, Jabbary Lak F, Mohammadi F. Assessment of inpatients with idiopathic inflammatory myopathies: A 10-year single unit experience. Egyptian Rheumatologist 2019;41:53–57.
- Lourenço T, Vale N. Entecavir: A Review and Considerations for Its Application in Oncology. Pharmaceuticals 2023;16:1–12.
- Shih CA, Chen WC. Prevention of hepatitis B reactivation in patients requiring chemotherapy and immunosuppressive therapy. World J Clin Cases 2021;9:5754–6177.
